You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

REGO

Cancer Type: Gastrointestinal, Gastrointestinal Stromal Tumours, Sarcoma, GIST      Intent: Palliative
Regimen Category: Evidence-Informed
Funding:
Exceptional Access Program
    regorafenib - For the treatment of metastatic and/or unresectable gastrointestinal stromal tumors (GIST), according to specific criteria.

You might also be interested in